- Home
- TEVA vs TLN Comparison
TEVA vs TLN Comparison
Compare TEVA & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- TLN
- Stock Information
- Founded
- TEVA 1901
- TLN 2015
- Country
- TEVA Israel
- TLN United States
- Employees
- TEVA N/A
- TLN N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- TLN Electric Utilities: Central
- Sector
- TEVA Health Care
- TLN Utilities
- Exchange
- TEVA Nasdaq
- TLN Nasdaq
- Market Cap
- TEVA 21.2B
- TLN 18.4B
- IPO Year
- TEVA N/A
- TLN N/A
- Fundamental
- Price
- TEVA $18.39
- TLN $408.09
- Analyst Decision
- TEVA Strong Buy
- TLN Strong Buy
- Analyst Count
- TEVA 7
- TLN 13
- Target Price
- TEVA $24.71
- TLN $349.23
- AVG Volume (30 Days)
- TEVA 10.3M
- TLN 1.1M
- Earning Date
- TEVA 11-05-2025
- TLN 11-13-2025
- Dividend Yield
- TEVA N/A
- TLN N/A
- EPS Growth
- TEVA N/A
- TLN N/A
- EPS
- TEVA N/A
- TLN 3.80
- Revenue
- TEVA $16,628,000,000.00
- TLN $2,128,000,000.00
- Revenue This Year
- TEVA $4.07
- TLN $16.21
- Revenue Next Year
- TEVA $0.81
- TLN $55.42
- P/E Ratio
- TEVA N/A
- TLN $107.36
- Revenue Growth
- TEVA 2.08
- TLN 1.09
- 52 Week Low
- TEVA $12.47
- TLN $148.02
- 52 Week High
- TEVA $22.80
- TLN $413.00
- Technical
- Relative Strength Index (RSI)
- TEVA 49.75
- TLN 69.02
- Support Level
- TEVA $18.46
- TLN $397.91
- Resistance Level
- TEVA $19.98
- TLN $410.00
- Average True Range (ATR)
- TEVA 0.50
- TLN 12.63
- MACD
- TEVA -0.10
- TLN 1.12
- Stochastic Oscillator
- TEVA 23.68
- TLN 90.17
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.